Hutchmed (China)
- Market cap
- 2.49B
- P/E (TTM)i
- 178.50
- P/Bi
- 1.98
- EPSi
- 2.60
- Div yieldi
- 0.00%
- 52W posi
- 69%
Anonymous reader poll. Unscientific, not investment advice.
About Hutchmed (China)
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
- Founded
- 2000
- CEO
- Mr. Johnny Cheng Chig FUNG
- Employees
- 1,796
- Headquarters
- Hong Kong，China, HK, China
- Fiscal year end
- 12-31
- Website
- hutch-med.com
Company profile
- Exchange
- US
- Symbol
- HCM
- Market-cap rank
- #2639
- Listing date
- 2016-03-17
- Market cap
- 2.49B
- Float cap
- 1.48B
- Shares out
- 174.47M
- Float shares
- 103.82M
Sectors & themes
Quote time 2026-10-08 04:18:46 · For reference only, not investment advice and not tailored to your situation.